- Category
- Micro (2022-23)
- Udyam number
- UDYAM-DL-02-0031070

Medisum Biotech Private Limited
About Medisum Biotech Private Limited
Data last updated:
Medisum Biotech Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 May 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24297DL2022PTC398224. Its GSTIN is 07AAPCM7624N1ZQ (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Varun Aggarwal and Ankush Aggarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 5/16 Krishna Nagar, Delhi, India – 110051.
As per the financials filed for FY 2024, the company reported a revenue of ₹9 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹11.41 Lakh (net margin 1.3%) and EBITDA of ₹29.97 Lakh (EBITDA margin 3.3%).
Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 2 cases are pending.
Medisum Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0031070).
Company details
Recognitions & Rankings of Medisum Biotech
Contact details
Medisum Biotech Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressE – 5/16 Krishna Nagar, Delhi, India – 110051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medisum Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medisum Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medisum Biotech Private Limited, buy the company report.
Financials of Medisum Biotech Private Limited
FY 2025 filings availableMedisum Biotech Private Limited reported revenue of ₹9 Cr (up 449% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 449% in the latest year. EBITDA rose 735% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹29.97 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹11.41 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.3% | |
| Net Profit Margin | 1.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Medisum Biotech Private Limited, buy the company report.
Board of directors of Medisum Biotech Private Limited
Medisum Biotech has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Varun Aggarwal Also directs: Sidhi Vinayak Pharma Private Limited | Director | 12 May 2022 | 4 Years 6 Months | Current |
| Ankush Aggarwal Also directs: Sidhi Vinayak Pharma Private Limited | Director | 12 May 2022 | 4 Years 6 Months | Current |
| Krishan Gopal Also directs: Sidhi Vinayak Pharma Private Limited | Director | 12 May 2022 | 4 Years 6 Months | Current |
| Tarun Aggarwal | Director | 12 May 2022 | 4 Years 6 Months | Current |
Peer comparison
Medisum Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abicee Pharmaceuticals Pvt Ltd | ₹9.03 Cr (FY 2023) | -8.0% | Bhubaneswar, Odisha, India | |||
| Medisum Biotech Private Limitedthis company | ₹9 Cr (FY 2024) | ₹11.41 Lakh | 1.3% | 449.0% | Delhi, India | |
| Altova Healthcare Limited | ₹8.96 Cr (FY 2024) | 7.0% | Mumbai, Maharashtra, India | |||
| Aies Pharma Chem Private Limited | ₹8.95 Cr (FY 2025) | 36.0% | Kalol, Gujarat, India |
To see the full peer comparison of Medisum Biotech Private Limited, buy the company report.
Auditor
Medisum Biotech Private Limited is audited by A P V & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A P V & ASSOCIATES | FY 2023 | 123143W |
Shareholding
The shareholding of Medisum Biotech Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medisum Biotech Private Limited, buy the company report.
Legal cases
Medisum Biotech Private Limited has 2 court cases on record: 1 filed by Medisum Biotech, 1 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Dehradun, Uttarakhand | Interim or miscellaneous application | Filed against the company by Boehringer Ingelheim India Pvt. Ltd. and 1 other | Pending |
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against Elixolife Pharmaceuticals | Pending |
To see the full case history of Medisum Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medisum Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medisum Biotech Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
Medisum Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAPCM7624N1ZQ | Delhi | Active | 09 Jun 2022 |
To see the full GST registrations and return filing status of Medisum Biotech Private Limited, buy the company report.
Recent activity
Medisum Biotech Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Ankush Aggarwal was appointed as Director on 12 May 2022.
Frequently asked questions
Medisum Biotech is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 May 2022 (4+ years old) and is registered under CIN U24297DL2022PTC398224.
Medisum Biotech has 4 current directors:
- Varun Aggarwal - Director
- Ankush Aggarwal - Director
- Krishan Gopal - Director
- Tarun Aggarwal - Director
The latest financial statements of Medisum Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Medisum Biotech is 07AAPCM7624N1ZQ, registered in Delhi.
The CIN (Corporate Identification Number) of Medisum Biotech is U24297DL2022PTC398224. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medisum Biotech has 2 court cases on record: 1 filed by the company and 1 filed against it. 2 are pending.
Medisum Biotech was incorporated on 12 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medisum Biotech by revenue are Abicee Pharmaceuticals Pvt Ltd, Altova Healthcare Limited, Aies Pharma Chem Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ankush Aggarwal was appointed as Director on 12 May 2022. Krishan Gopal was appointed as Director on 12 May 2022. Tarun Aggarwal was appointed as Director on 12 May 2022. Medisum Biotech has 4 board changes on record in total.
Yes, Medisum Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0031070).
The registered office of Medisum Biotech is at E – 516 Krishna Nagar, Delhi, India – 110051.

